Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Olschewski, H; Behr, J; Bremer, H; Claussen, M; Douschan, P; Halank, M; Held, M; Hoeper, MM; Holt, S; Klose, H; Krüger, S; Lange, TJ; Reichenberger, F; Skowasch, D; Ulrich, S; Wilkens, H; Seeger, W.
Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018.
INT J CARDIOL. 2018; 272S(10): 63-68.
Doi: 10.1016/j.ijcard.2018.08.043
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Olschewski Horst
- Co-Autor*innen der Med Uni Graz
- Douschan Philipp
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The 2015 European Guidelines on Pulmonary Hypertension did not only cover pulmonary arterial hypertension (PAH) but also some aspects of pulmonary hypertension (PH) associated with chronic lung disease. The European Guidelines point out that the drugs currently used to treat patients with PAH (prostanoids, endothelin receptor antagonists, phosphodiesterase‑5 inhibitors, sGC stimulators) have not been sufficiently investigated in other forms of PH. Therefore, the European Guidelines do not recommend the use of these drugs in patients with chronic lung disease and PH. This recommendation, however, is not always in agreement with medical ethics as physicians sometimes feel inclined to treat other forms of PH which may affect quality of life and survival of these patients in a similar manner. To this end, it is crucial to consider the severity of both PH and the underlying lung disease. In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Paediatric Cardiology (DGPK) was held in Cologne, Germany, to discuss open and controversial issues surrounding the practical implementation of the European Guidelines. Several working groups were created, one of which was dedicated to the diagnosis and treatment of PH in patients with chronic lung disease. The 2018 updated recommendations of this working group are summarized in the present paper. Copyright © 2018. Published by Elsevier B.V.
- Find related publications in this database (using NLM MeSH Indexing)
- Consensus Development Conferences as Topic -
- Consensus Development Conferences as Topic - epidemiology
- Humans -
- Hypertension, Pulmonary - diagnosis
- Hypertension, Pulmonary - epidemiology
- Hypertension, Pulmonary - therapy
- Lung Diseases - diagnosis
- Lung Diseases - epidemiology
- Lung Diseases - therapy
- Practice Guidelines as Topic - standards
- Find related publications in this database (Keywords)
- Pulmonary hypertension
- Lung disease
- COPD
- Pulmonary fibrosis
- Therapy